Skip to content
LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”
LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation
LinusBio Named “Fierce 15” Company of 2023 by Fierce Medtech
LinusBio Raises $16 Million to Scale Growth and Deliver Tangible Outcomes
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
LinusBio Recognized at the 2022 Mount Sinai Innovation Awards
WATCH: Detecting Autism at Birth and Opportunity for Early Intervention